Company Overview of MRIGlobal, Inc.
MRIGlobal, Inc., a not-for-profit research and development organization, provides contract research and development, test and evaluation, and operations and management services for government, industry, and academia customers in the United States and internationally. The company focuses on developing food and energy supplies. It conducts programs in the areas of national security and defense, life and animal sciences, energy and environment, agriculture and food safety, and engineering and infrastructure. The company offers technology solutions in chemical, biological, radiological, nuclear, and explosive fields for the U.S. Government and the defense industry; services in renewable, alterna...
425 Volker Boulevard
Kansas City, MO 64110-2241
Founded in 1943
Key Executives for MRIGlobal, Inc.
Chief Executive Officer and President
Chief Financial Officer, Executive Vice President and Treasurer
Vice President and General Counsel
Chief Advisor for Science
Executive Vice President and Director of National Renewable Energy Laboratory
Compensation as of Fiscal Year 2014.
MRIGlobal, Inc. Key Developments
MRIGlobal Wins Contract to Develop Whole Genome Sequencing Diagnostic System
Feb 23 15
MRIGlobal announced that it has been awarded a $14.8 million contract to develop an end-to-end next generation sequencing system for clinical diagnosis of infectious diseases. MRIGlobal's proposed Sample-to-Sequence system will take clinical samples (blood or saliva, for example) and generate high-quality whole genome sequences of bacteria and viruses. The diagnostic tool will be able to identify a broad range of human pathogens, from a single sample with particular emphasis on emerging pathogens and those not identifiable by available rapid diagnostic methods. With the Sample-to-Sequence system, a clinician will send a single sample to a laboratory for sequencing. The genomes uncovered in the sample will be identified against a developed database of microorganisms capable of causing infectious diseases.
MRIGlobal Wins $54 Million NIH Neurological Disorders and Stroke Contract To Support Drug Development
Jan 15 15
MRIGlobal announced that it has been awarded a $54 million, 10-year program from the National Institute of Neurological Disorders and Stroke to provide support for the development and manufacturing of drug candidates for ultimate use in human clinical trials. The project entails process development and preparation of active pharmaceutical ingredients (API); pre-formulation and formulation studies; analytical method development and validation; stability studies; drug product manufacturing, packaging, labeling; and storage and distribution of the drug products for clinical trials.
MRIGlobal Announces Launch of CBRNE Tech Index
Jan 13 15
MRIGlobal announced the launch of CBRNE Tech Index, a comprehensive database of Chemical, Biological, Radiological, Nuclear and Explosive (CBRNE) detection equipment. CBRNE Tech Index allows users to view, compare, and filter products according to dozens of technology categories. It assists users in determining the most suitable equipment by comparing verifiable metrics of available products. The site aims to provide a venue for manufacturers to display products and allow the users to view, search, compare, and assess features. It enables users to make informed decisions on which product meets their needs. CBRNE Tech Index capitalizes on decades of MRIGlobal experience with independent testing, evaluation, and validation of analytical instruments and methods for government and industrial clients. CBRNE Tech Index is the one-stop-shop for those looking to research equipment, sensors, and products related to the analysis, detection, or identification of threat materials and everyday chemical and biological compounds.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|